Parallax Volatility Advisers
RPTP

Parallax Volatility Advisers’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Parallax Volatility Advisers’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-200,000
Closed -$1.04M – 4549
2015
Q4 		$1.04M Buy
200,000
+63,200
+46% +$367K ﹤0.01% 1264
2015
Q3 		$827K Buy
136,800
+100,000
+272% +$1.23M ﹤0.01% 1357
2015
Q2 		$581K Buy
+36,800
New +$447K ﹤0.01% 1557

Parallax Volatility Advisers's RPTP Position: Q4 2016 in Review

Parallax Volatility Advisers sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 26,775 shares — an estimated $240K sold.

Parallax Volatility Advisers first reported a position in RPTP in Q2 2015 and held it in 6 quarters. The position peaked at $501K in Q1 2016. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • Parallax Volatility Advisers reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • Parallax Volatility Advisers sold 26,775 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $240K.
  • Parallax Volatility Advisers first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2015 and held it in 6 quarters.
  • Parallax Volatility Advisers's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $501K in Q1 2016.
  • 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Parallax Volatility Advisers's 13F filing for Q4 2016, filed 14 Feb 2017.